PRL and breast cancer: Restraint stress facilitates the development of dimethyl benzanthracene (DMBA) induced mammary tumors by releasing β-endorphin and prolactin, However, naltrexone, an opioid receptor antagonist, exerts a beneficial effect by opposing the effect of β-endorphin on prolactin release in stressed animals (109).